8-K
filed August 26, 2022, 7:59 PM ET
ticker RGPX
CIK 0001357878
leadership
confidence high
sentiment neutral
materiality 0.50
Regenerex Pharma announces CFO, director resignations; appoints Lee Ori to board, Deborah Pilant as CFO
REGENEREX PHARMA, INC.
- Irene Getty resigned as CFO, Bruce Sellars resigned from board, Byron Striloff resigned as officer, all effective Aug 25, 2022.
- Dr. Lee Ori appointed to board effective Aug 25; he also serves as COO. Background: pharmacy doctorate, Eli Lilly, multiple pharmacist licenses.
- Deborah L. Pilant appointed CFO effective Aug 25; already serving as Secretary/Treasurer and Director. Background in education, construction, sales.
- No reason given for departures or any financial impact disclosed.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Irene Getty resigned as Chief Financial Officer at REGENEREX PHARMA, INC..
- Action
- resigned
- Role
- Chief Financial Officer
Exact text from the filing
Effective August 25, 2022, Irene Getty tendered her letter of resignation to the Company resigning from her positions as Chief Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bruce Sellars resigned as Director at REGENEREX PHARMA, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Effective August 25, 2022, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as a member of the Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Deborah L. Pilant was appointed as Chief Financial Officer at REGENEREX PHARMA, INC..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
Effective August 25, 2022, Deborah L. Pilant has been appointed to serve as Chief Financial Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Byron Striloff resigned as other_named_officer at REGENEREX PHARMA, INC..
- Action
- resigned
Exact text from the filing
Effective August 25, 2022, Byron Striloff tendered his letter of resignation to the Company resigning from his position as an Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Lee Ori was appointed as Director at REGENEREX PHARMA, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective August 25, 2022, Dr Lee Ori has been elected/appointed to the Board of Directors of the Company.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.